Sema4 Achieves HITRUST CSF Certification
06 4월 2022 - 9:00PM
Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data
intelligence platform company, today announced that its health
intelligence platform, Centrellis®, has earned Certified status for
information security by the Health Information Trust (HITRUST)
Alliance.
HITRUST CSF (Common Security Framework) Certified status
demonstrates that Sema4’s Centrellis platform has met
industry-defined health information security requirements and is
appropriately managing risk. This achievement places Sema4 in an
elite group of organizations worldwide that have earned this
certification.
“We are pleased to receive this prestigious certification from
HITRUST, which further underscores our commitment to the highest
possible levels of data security and privacy and to treating
patients as partners,” said Andrew Kasarskis, PhD, Chief Data
Officer, Sema4. “We will continue to prioritize the utilization of
best-in-class tools and systems to safeguard all patient
information and other data as we accelerate our mission of
transforming healthcare.”
Sema4’s Centrellis integrated health information platform is one
of the largest and fastest growing in existence, providing
data-driven insights to enable personalized medicine. It has
approximately 12 million de-identified clinical records, including
more than 500,000 with genomic profiles. As one of the most
sophisticated systems in the world, the data-driven insights from
the Centrellis platform offer health system partners, clinicians,
and patients a more complete understanding of disease and
wellness.
“The HITRUST Assurance Program is the most rigorous available,
consisting of a multitude of quality assurance checks, both
automated and manual,” said Bimal Sheth, Executive Vice President,
Standards Development & Assurance Operations, HITRUST. “The
fact that Sema4 has achieved HITRUST Risk-based, 2-year
Certification attests to the high quality of their information risk
management and compliance program.”
About Sema4
Sema4 is a patient-centered health intelligence
company dedicated to advancing healthcare through data-driven
insights. Sema4 is transforming healthcare by applying AI and
machine learning to multidimensional, longitudinal clinical and
genomic data to build dynamic models of human health and defining
optimal, individualized health trajectories. Centrellis®, our
innovative health intelligence platform, is enabling us to generate
a more complete understanding of disease and wellness and to
provide science-driven solutions to the most pressing medical
needs. Sema4 believes that patients should be treated as partners,
and that data should be shared for the benefit of all.
For more information, please visit sema4.com and
connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.
Media Contact:Radley
Mossradley.moss@sema4.com
Sema4 (NASDAQ:SMFRW)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Sema4 (NASDAQ:SMFRW)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025